Gene Query: KCTD3

Dataset Description Geneva Score
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 62.4
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 62.4
Transcriptomic analysis of LSD1 40.33
IL-33 activates tumor stroma to promote intestinal polyposis 33.6
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 32.46
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 30.0
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 28.9
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 27.62
HNF1 regulates critical functions of the human epididymis epithelium. 27.62
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 26.85
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 25.29
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 24.79
EGR1-controlled transcriptome of T HESCs 23.45
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 22.92
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 22.92
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 22.64
Genome-wide analysis of the Integrator complex 22.08
Genome-wide analysis of the Integrator complex (HTS) 22.08
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 22.01
Transcriptomic analysis of ERR alpha orphan nuclear receptor 21.08
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 20.53
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 20.23
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 20.01
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 19.87
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 19.85
An RNA-centric dissection of host complexes controlling flavivirus infection 19.42
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 19.42
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 19.39
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 19.04
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 18.62
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 18.39
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 18.06
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 17.63
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 17.47
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 17.37
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 17.18
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 16.83
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 16.82
Region-specific Innate Antiviral Responses of the Human Epididymis 16.51
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 16.47
Mutational landscape of splicing genes and functional consequences across 33 cancer types 16.37
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 16.32
The cohesin release factor WAPL restricts chromatin loop extension. 16.21
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 16.21
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 16.14
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 16.13
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 16.13
Expression profiling of etoposide-induced senescent cells 15.88
AR-independent prostate cancer is sustained through FGF signaling 15.84
Sensing self and nonself circular RNAs 15.81
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 15.48
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 15.48
RNA-sequencing of formalin fixed human primary melanoma tissue 15.4
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 15.24
Gene expression analysis of dengue-infected cells 15.2
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 15.14
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 14.77
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 14.62
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 14.62
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 14.6
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 14.02
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 14.0
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 13.85
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 13.83
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 13.58
Transcriptomic analyssis following EHMT1/2 inhibition 13.53
ETV7 and interferon response 13.37
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 13.37
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 13.25
EP400 is required for Max and MCPyV mediated gene activation 13.05
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 12.97
Silencing SPIB in attached and floating state of H1703 lung cancer cells 12.96
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 12.84
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 12.75
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 12.61
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 12.61
The pause-initiation limit restricts transcription activation in human cells 12.6
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 12.59
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 12.54
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 12.35
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 12.35
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 12.03
Global analysis of alternative splicing regulated by RBM10 12.0
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 11.93
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 11.7
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.56
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 11.5
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.45
Genes significantly down or Up-regulated upon RNF219 knockdown 11.26
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 11.21
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 11.13
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.1
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.05
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 11.05
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 11.01
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 11.01
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 10.93
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 10.93
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 10.86
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 10.72
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 10.72
MYCi361 regulates MYC target genes 10.68
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 10.63
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 10.62
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 10.41
JAK dependent survival of ALK- ALCL 10.4
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 10.38
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 10.26
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 10.23
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 10.22
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.2
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 10.18
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 10.18
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 9.92
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 9.84
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 9.84
RNA-seq analysis of RALD iPSCs after in vitro differentiation 9.75
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 9.73
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 9.73
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 9.73
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 9.73
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.69
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 9.69
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 9.69
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 9.6
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 9.6
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.56
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.56
3’ Uridylation Expands miRNA Target Repertoire 9.52
MYCi975 regulates MYC target genes 9.52
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.51
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.5
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 9.47
SETBP1-WT and SETBP1-G870S epigenetic landscapes 9.47
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.45
Targeting MTHFD2 in Acute Myeloid Leukemia 9.41
Biological effect of chronic mistranslation in mammalian cells 9.36
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 9.33
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 9.32
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 9.19
RNA-seq analysis to identify the genes regulated by p53-SET interplay 9.17
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.13
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 9.12
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 9.1
Gene expression changes associated with resistance to tagraxofusp (SL-401) 9.09
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 9.05
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 9.05
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 9.04
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 9.04
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 9.03
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.01
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.95
Ebola virus (EBOV) infection of ARPE-19 cells 8.95
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.91
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 8.9
RNA-Seq with and without RNase treatment in PCa cell lines 8.88
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 8.84
Control of prostate tumour growth by the long non-coding RNA GHSROS 8.82
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 8.82
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 8.74
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 8.74
Genome-wide analysis of Dengue virus 2 infected cells 8.71
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 8.68
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 8.68
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 8.62
Effect of Influenza virus infection on lncRNA expression in A549 cells 8.58
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 8.57
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 8.52
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 8.52
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 8.51
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 8.5
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 8.48
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 8.47
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.46
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 8.43
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.42
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.39
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 8.38
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.36
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.36
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 8.35
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 8.33
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 8.32
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 8.32
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 8.32
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.29
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 8.29
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.28
Overexpression and knockdown experiment for circCSNK1G3 8.21
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.19
A sister of NANOG regulates genes expressed in pre-implantation human development 8.19
RNA-sequencing of human liver tissue 8.18
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 8.18
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.17
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 8.1
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.09
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 8.03
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.03
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 7.97
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 7.91
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 7.89
Differetially expressed genes after hTR overexpression in U2OS cells 7.89
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 7.88
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 7.86
Selective suppression of endothelial cytokine production by progesterone receptor 7.86
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.85
Transcriptome-wide identification of CELF2 functional targets in T cells 7.83
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.82
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.77
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 7.75
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 7.75
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.74
RNA-seq of MCF10A cells and CAF 7.69
RNA-sequencing in irradiated and normal A549 cells. 7.69
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.67
Role of CD133 molecule in WNT response and renal repair 7.63
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 7.61
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 7.6
Expression data from miR340 overexpressing human A549 cells 7.58
Gene expression changes upon drug withdrawal (Mel888 cell line) 7.56
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.54
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.53
Gene expression in PANC1 cells treated with Rakicidin 7.47
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 7.45
Determination of tRNA aminoacylation levels by high throughput sequencing 7.45
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 7.43
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 7.43
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 7.42
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 7.4
Identification of Nrf2 regulated genes by RNA sequencing 7.4
Nrf2 regulated genes in A549 cells 7.4
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 7.37
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 7.33
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 7.28
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 7.27
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 7.26
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 7.26
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 7.18
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.17
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.09
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 7.04
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.04
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.02
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 7.01
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.01
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 6.91
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 6.9
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.89
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 6.89
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.88
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.84
Global Mapping of Human RNA-RNA Interactions 6.82
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.8
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.8
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 6.78
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 6.78
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 6.78
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 6.78
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 6.76
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.74
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.72
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 6.72
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 6.64
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 6.54
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.53
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.53
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 6.53
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 6.29
The role of CFTR in islet function 6.27
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 6.25
Genome-wide discovery of human splicing branchpoints 6.25
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.21
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 6.2
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 6.2
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 6.19
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 6.19
Regulation of Lipids is Central to Replicative Senescence 6.19
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 6.17
The transcriptome effect of overexpressing EZH2 in MCF7 6.14
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.13
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.13
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 6.13
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.06
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 6.06
PGE2 mediated gene expression changes in human cervical stromal cells 6.06
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.93
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.93
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 5.93
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.92
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.84
RNA-seq melanoma 5.84
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 5.8
Real-time observation of light-controlled transcription in living cells 5.79
Molecular Criteria for Defining the Naive Human Pluripotent State 5.75
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 5.72
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 5.71
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.69
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 5.69
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 5.68
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 5.67
METTL3 and WTAP 5.63
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 5.6
DAOY-Notch1/Notch2 knockout: transcriptome comparison 5.6
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 5.53
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.44
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.43
Mitochondrial dsRNA triggers antiviral signalling in humans 5.42
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 5.33
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.3
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.27
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 5.27
RNAseq of cell lines with knocked in ESR1 mutations 5.24
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 5.24
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.21
SLIGRL-induced gene expression changes in NHEK cells 5.2
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 5.19
Gene expression profile of multiple myeloma cell lines treated with CB-5083 5.18
Systematic discovery of endogenous human ribonucleoprotein complexes 5.15
Gene expression in GBM with Cav3.2 inhibition 5.09
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.05
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.05
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 5.0
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 5.0
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.99
Gene expression analysis of breast cancer cell-lines 4.96
Gene expression and genome-wide location analysis of breast cancer cell-lines 4.96
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 4.96
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.94
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.85
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.82
RNA-seq of RKO cells with cTAZ KO or putback 4.81
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 4.81
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.78
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.77
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 4.73
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.71
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.68
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.67
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 4.52
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 4.5
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.49
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 4.46
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 4.41
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.4
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 4.36
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 4.36
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 4.34
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.34
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 4.31
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 4.31
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.29
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.28
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.23
Enhancer activation during EGF response 4.23
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.2
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.19
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 4.19
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.04
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.0
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.97
Expression profiling of MCF-7 cells with treatment of TCDD 3.97
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.94
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.89
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.85
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.81
Dynamic 3D chromosomal landscapes in acute leukemia 3.81
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.81
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.8
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.8
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 3.79
Next generation sequencing of small RNAs isolated from exosomes in human semen 3.75
6mer seed toxicity in tumour suppressive microRNAs 3.71
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.67
Regulatory network controlling tumor-promoting inflammation in human cancers 3.67
K562 polyA RNA-Seq 3.64
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.61
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 3.54
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.54
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 3.51
mRNA recovered upon RNF219 IP. [RNA-IP] 3.47
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.43
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.34
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 3.32
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.31
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.31
In vitro modeling of human germ cell development using pluripotent stem cells 3.29
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.26
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.22
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.22
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.04
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.04
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.04
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.04
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 3.01
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 3.0
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.96
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.96
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.96
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.94
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.75
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.74
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.7
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.7
Age-Related Gene Expression Changes in Prostate Cancer Patients 2.64
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 2.64
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.52
Exploring ILF2 regulatory genes by next-generation sequencing 2.41
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.4
RNAseq of T-ALL upon long non coding rna purturbation 2.22
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.2
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.16
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 2.16
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.14
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.14
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.13
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.13
Persistence of stem cell metabolism in cancers as a failure of differentiation 2.11
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 2.1
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 2.1
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.09
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.05
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 2.04
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.03
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.99
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.99
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.98
Epigenomic conservation of transposable element silencing 1.92
Epigenomic conservation of transposable element silencing [RNA-seq] 1.92
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.84
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.71
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.71
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 1.7
Measure transcript integrity using RNA-seq data 1.65
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.63
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.57
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.55
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.55
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.55
RNA-seq analysis of control and Myc-induced U2OS cells 1.42
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.41
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.37
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.36
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.36
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.36
RNA seq_PDX2_SHP099 1.34
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.23
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.2
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 1.2
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 1.2
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 1.2
RNA-seq of shEZH2 cells 1.2
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.13
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.07
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.07
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 1.05
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 1.05
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.03
HBEC-shp53-PCHD7 1.01
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.9
RNA-Seq of PRMT1 overexpression ECA109 cells 0.9
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.89
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.85
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.85
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.82
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.82
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.8
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.8
SOX11 knockdown in B-ALL cell lines 0.74
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.72
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.71
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.69
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.68
Leucegene: ALL sequencing 0.68
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 0.48
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.47
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.46
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.44
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.41
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.41
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.41
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.38
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.37
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.37
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.36
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.35
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.35
The contribution of Alu exons to the human proteome 0.31
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.27
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.27
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.2
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.17
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.1
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.1
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.07
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Modulation of nonsense-mediated decay by rapamycin 0.01
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.0
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation